{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:57:38Z","timestamp":1784408258528,"version":"3.55.0"},"reference-count":27,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OVS"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Elevated prolactin levels may have several etiologies, one of which is a prolactinoma. Prolactinomas, the most prevalent pituitary tumors, may be more common than once described. These tumors can result in ocular complications such as vision loss and visual field defects. Prolactinomas are easily treated but need to be identified early in order to prevent more serious systemic complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report<\/jats:title>\n                    <jats:p>A 24\u2010year\u2010old Pacific Islander male presented with sudden blurred vision and an associated visual field defect in the right eye for 4 to 6 months. After performing a magnetic resonance imaging and consultation with an endocrinologist, the patient was diagnosed with a prolactinoma. The patient was treated and demonstrated a complete recovery of visual acuity and visual field defect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prolactinomas are a common pituitary tumor characterized by an increase in prolactin levels. This review describes how prolactinomas are classified, their etiology, subsequent complications, and treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/opx.0b013e31826b094b","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T15:47:37Z","timestamp":1349279257000},"source":"Crossref","is-referenced-by-count":6,"title":["Prolactinomas and the Eye"],"prefix":"10.1002","volume":"89","author":[{"given":"Makesha","family":"Sink","sequence":"first","affiliation":[{"name":"VA Health Administration, VAMC Hampton Hampton Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel","family":"Chou","sequence":"additional","affiliation":[{"name":"VA Health Administration, VAMC Hampton Hampton Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00046427","article-title":"Diagnosis and management of prolactinomas","volume":"5","author":"Dollar JR","year":"1986","journal-title":"Cancer Metastasis Rev"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","article-title":"Pituitary tumours: the prolactinoma","volume":"23","author":"Colao A","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli A","year":"2005","journal-title":"Pituitary"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2362.2010.02399.x","article-title":"Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach","volume":"41","author":"Mann WA","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2002-36709","article-title":"Hyperprolactinemia: etiology, diagnosis, and management","volume":"20","author":"Mah PM","year":"2002","journal-title":"Semin Reprod Med"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s007010170075","article-title":"Clinical features and medical treatment of male prolactinomas","volume":"143","author":"Asano S","year":"2001","journal-title":"Acta Neurochir (Wien)"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1012905415868","article-title":"Current management of prolactinomas","volume":"54","author":"Nomikos P","year":"2001","journal-title":"J Neurooncol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva FF","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-005-5087-0","article-title":"Combined treatment of invasive giant prolactinomas","volume":"8","author":"Yu C","year":"2005","journal-title":"Pituitary"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11102-005-5080-7","article-title":"Pathogenesis of prolactinomas","volume":"8","author":"Spada A","year":"2005","journal-title":"Pituitary"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1471-7697(03)00060-1","article-title":"Prolactinomas in infertility","volume":"3","author":"Kaur K","year":"2003","journal-title":"Rev Gynaecol Prac"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1383\/medc.2005.33.11.16","article-title":"Prolactin disorders","volume":"33","author":"Todd JF","year":"2005","journal-title":"Medicine"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.survophthal.2005.09.001","article-title":"Her vision was tied down","volume":"50","author":"Dorotheo EU","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10330-007-0145-x","article-title":"Diagnosis and treatment of prolactinoma: clinical analysis of 124 prolactinomas","volume":"7","author":"Han L","year":"2008","journal-title":"Chinese\u2010German J Clin Oncol"},{"key":"e_1_2_6_16_1","first-page":"181","article-title":"Absence of the relative afferent pupillary defect with monocular temporal visual field loss","volume":"12","author":"Kosmorsky GS","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"key":"e_1_2_6_17_1","first-page":"147","article-title":"Unusual visual manifestations of pituitary tumors","volume":"19","author":"Dhar MY","year":"2007","journal-title":"Kerala J Ophthalmol"},{"key":"e_1_2_6_18_1","first-page":"52","article-title":"Neuro\u2010ophthalmic manifestations and outcomes of pituitary apoplexy\u2014a life and sight\u2010threatening emergency","volume":"124","author":"Simon S","year":"2011","journal-title":"N Z Med J"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/beem.1999.0030","article-title":"Clinical management of prolactinomas","volume":"13","author":"Webster J","year":"1999","journal-title":"Baillieres Best Pract Res Clin Endocrinol Metab"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder K","year":"2011","journal-title":"Pituitary"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/ENDO:28:1:101","article-title":"Treatment of pituitary tumors: dopamine agonists","volume":"28","author":"Ivan G","year":"2005","journal-title":"Endocrine"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea","volume":"331","author":"Webster J","year":"1994","journal-title":"N Engl J Med"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","article-title":"Pharmacologic resistance in prolactinoma patients","volume":"8","author":"Molitch ME","year":"2005","journal-title":"Pituitary"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.beem.2011.05.011","article-title":"Prolactinoma in pregnancy","volume":"25","author":"Molitch ME","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02738730","article-title":"Incidence, pathology, and recurrence of pituitary adenomas: study of 647 unselected surgical cases","volume":"6","author":"Terada T","year":"1995","journal-title":"Endocr Pathol"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4103\/0028-3886.84332","article-title":"Microsurgical management of prolactinomas\u2014clinical and hormonal outcome in a series of 172 cases","volume":"59","author":"Sinha S","year":"2011","journal-title":"Neurol India"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2008.03364.x","article-title":"Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma","volume":"70","author":"Raverot G","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00041327-200206000-00008","article-title":"Delayed visual loss following pergolide treatment of a prolactinoma","volume":"22","author":"Chuman H","year":"2002","journal-title":"J Neuroophthalmol"}],"container-title":["Optometry and Vision Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31826b094b","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1097\/OPX.0b013e31826b094b","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31826b094b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:57:34Z","timestamp":1774951054000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/OPX.0b013e31826b094b"}},"subtitle":["A Clinical Case and Review"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1097\/OPX.0b013e31826b094b"],"URL":"https:\/\/doi.org\/10.1097\/opx.0b013e31826b094b","archive":["Portico"],"relation":{},"ISSN":["1040-5488","1538-9235"],"issn-type":[{"value":"1040-5488","type":"print"},{"value":"1538-9235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}